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background: B Type Natriuretic Peptide (BNP) levels have been shown to predict Ventricular Arrhythmia (VA) and sudden death in heart failure. We 
sought to determine whether BNP can predict VA post Left Ventricular Assist Device (LVAD) implantation.
Methods: We conducted a retrospective nested case-control study consisting of patients who underwent LVAD implantation in our institution 
during 5.2009-3.2013. The study was limited to patients receiving a Heartmate II or Heartware LVAD. Acute myocardial infarction patients with 
cardiogenic shock were excluded. We then compared between patients who developed VA (within 15 days post LVAD implantation) and patients 
without VA. Pre-LVAD BNP level was defined as a patient’s maximal BNP measurement during the 4 months preceding LVAD implantation.
results: A total of 85 patients underwent VAD implantation during the study period. 11 patients were excluded (5 acute MI, 2 discharged early, and 
4 without BNP levels). The incidence of VA was 31%. Among patients with VA, there were no significant electrolyte abnormalities and 87% of patients 
received inotropic support. BNP remained the single most powerful predictor of VA, even after adjustment for VA risk factors described in previous 
studies.
conclusions: BNP levels are a strong predictor of VA post LVAD implantation, surpassing previously described risk factors such as age and VA in 
the past. This underscores the adverse clinical course associated with extremely high BNP levels in heart failure patients.
